PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
679.42%
Some net income increase while CSIQ is negative at -26.90%. John Neff would see a short-term edge over the struggling competitor.
30.88%
D&A growth of 30.88% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
542.07%
Deferred tax of 542.07% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-0.53%
Both cut yoy SBC, with CSIQ at -69.71%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
16.99%
Working capital change of 16.99% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might affect near-term cash flow.
125.75%
AR growth of 125.75% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
749.51%
Inventory growth of 749.51% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
136.48%
AP growth of 136.48% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
-545.94%
Negative yoy usage while CSIQ is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-341.00%
Negative yoy while CSIQ is 113.59%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
477.41%
CFO growth of 477.41% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a modest edge that could widen if cost discipline remains strong.
-98.76%
Negative yoy CapEx while CSIQ is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-11918.40%
Negative yoy acquisition while CSIQ stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-891.13%
We reduce yoy other investing while CSIQ is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-384.47%
We reduce yoy invests while CSIQ stands at 0.00%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
32350.88%
Debt repayment growth of 32350.88% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
51.56%
Buyback growth of 51.56% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.